Tuberculosis in key populations in Tajikistan - a snapshot in 2017.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
16 11 2020
Historique:
received: 22 08 2019
accepted: 07 12 2019
entrez: 23 11 2020
pubmed: 24 11 2020
medline: 17 7 2021
Statut: epublish

Résumé

WHO End TB Strategy aims at achieving targets of 90% mortality reduction and 80% reduction in tuberculosis (TB) incidence by 2030, recommending better addressing TB and multidrug-resistant TB (MDR-TB) issues in key populations. The study aimed at having a snapshot of the epidemiological characteristics of the key populations among the new TB patients, registered in Tajikistan during 2017. A cross-sectional study was conducted, using official TB registration data for all new TB case notification in Tajikistan in 2017. The key population included 1,029 (19.8%) patients among all 5,182 new TB cases registered in 2017. The following selected sub-populations were identified: migrant workers - 728 (70.7%), diabetics - 162 (15.7%), HIV-positive - 138 (13.4%), heavy drinkers - 74 (7.2%), drug users - 50 (4.8%), ex-prisoners - 50 (4.8%), and homeless - 9 (0.9%). Among the key population, 307 (29.8%) patients were smear-positive, 145 (14.1%) were drug-sensitive and 116 (11.3%) had MonoDR/MDR-TB. Time to treatment initiation for smear-positive cases was ≤ 5 days for 303 (98.7%) patients. Being a key population was inversely related to gender (female) (OR = 0.25, 95% CI (0.21, 0.29)) and population type (rural) (OR = 0.64, 95% CI (0.55, 0.74)). Among the key population the identified overlaps of selected sub-populations would enable more efficiently reaching the certain groups. TB case detection at PHC levels needs to be targeted for improved rates for key population detection. In the key population sub-group of migrant workers' special migration destinations are recommended to be explored and find out possible associations with drug resistance.

Identifiants

pubmed: 33226966
doi: 10.3855/jidc.11952
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

94S-100S

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright (c) 2020 Zulfiya Tilloeva, Seda Aghabekyan, Karapet Davtyan, Olga Goncharova, Olim Kabirov, Bobojon Pirmahmadzoda, Asliddin Rajabov, Azamdzhon Mirzoev, Garry Aslanyan.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Zulfiya Tilloeva (Z)

Institute of Gastroenterology, Dushanbe, Tajikistan. ztilloeva@gmail.com.

Seda Aghabekyan (S)

Tuberculosis Research and Prevention Center NGO, Yerevan, Armenia. seda.aghabekyan@gmail.com.

Karapet Davtyan (K)

Tuberculosis Research and Prevention Center NGO, Yerevan, Armenia. davkaro@gmail.com.

Olga Goncharova (O)

National Center of Phthisiology, Bishkek, Kyrgyzstan. goncharova.ncph@gmail.com.

Olim Kabirov (O)

National Tuberculosis Reference Laboratory, Vahdat city, Shifo, Tajikistan. olim.kabirov@mail.ru.

Bobojon Pirmahmadzoda (B)

Republican Center of Protection of the Population from Tuberculosis, Dushanbe, Tajikistan. sharipovbobojon07@gmail.com.

Asliddin Rajabov (A)

Republican Center of Protection of the Population from Tuberculosis, Dushanbe, Tajikistan. asliddin.81@mail.ru.

Azamdzhon Mirzoev (A)

Institute for Post-Diploma Education in Health Care, Dushanbe, Tajikistan. azamdjon@mail.ru.

Garry Aslanyan (G)

Special Programme for Research and Training in Tropical Diseases, TDR, World Health Organization, Geneva, Switzerland. aslanyang@who.int.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH